Herbst RS - Search Results

1

Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer.

Hanrahan EO, Ryan AJ, Mann H, Kennedy SJ, Langmuir P, Natale RB, Herbst RS, Johnson BE, Heymach JV. Hanrahan EO, et al. Among authors: herbst rs. Clin Cancer Res. 2009 May 15;15(10):3600-9. doi: 10.1158/1078-0432.CCR-08-2568. Epub 2009 May 15. Clin Cancer Res. 2009. PMID: 19447868

2

Chemotherapy for advanced non-small cell lung cancer.

Herbst RS, Dang NH, Skarin AT. Herbst RS, et al. Hematol Oncol Clin North Am. 1997 Jun;11(3):473-517. doi: 10.1016/s0889-8588(05)70445-7. Hematol Oncol Clin North Am. 1997. PMID: 9209907 Review.

3

Gemcitabine and vinorelbine combinations in the treatment of non-small cell lung cancer.

Herbst RS, Lilenbaum R. Herbst RS, et al. Semin Oncol. 1999 Oct;26(5 Suppl 16):67-70; discussion 71-2. Semin Oncol. 1999. PMID: 10585011 Review.

4

Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.

Herbst RS, Yano S, Kuniyasu H, Khuri FR, Bucana CD, Guo F, Liu D, Kemp B, Lee JJ, Hong WK, Fidler IJ. Herbst RS, et al. Clin Cancer Res. 2000 Mar;6(3):790-7. Clin Cancer Res. 2000. PMID: 10741698

5

Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.

Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ. Yano S, et al. Among authors: herbst rs. Clin Cancer Res. 2000 Mar;6(3):957-65. Clin Cancer Res. 2000. PMID: 10741721

6

Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis.

Yano S, Shinohara H, Herbst RS, Kuniyasu H, Bucana CD, Ellis LM, Davis DW, McConkey DJ, Fidler IJ. Yano S, et al. Among authors: herbst rs. Cancer Res. 2000 Sep 1;60(17):4959-67. Cancer Res. 2000. PMID: 10987313

7

Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells.

Yano S, Shinohara H, Herbst RS, Kuniyasu H, Bucana CD, Ellis LM, Fidler IJ. Yano S, et al. Among authors: herbst rs. Am J Pathol. 2000 Dec;157(6):1893-903. doi: 10.1016/S0002-9440(10)64828-6. Am J Pathol. 2000. PMID: 11106562 Free PMC article.

8

Emerging therapies in non-small-cell lung cancer.

Khuri FR, Herbst RS, Fossella FV. Khuri FR, et al. Among authors: herbst rs. Ann Oncol. 2001 Jun;12(6):739-44. doi: 10.1023/a:1011197500223. Ann Oncol. 2001. PMID: 11484947 Free article. Review.

9

A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer.

Kim ES, Lu C, Khuri FR, Tonda M, Glisson BS, Liu D, Jung M, Hong WK, Herbst RS. Kim ES, et al. Among authors: herbst rs. Lung Cancer. 2001 Dec;34(3):427-32. doi: 10.1016/s0169-5002(01)00278-1. Lung Cancer. 2001. PMID: 11714540 Clinical Trial.

10

Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck.

Tseng JE, Glisson BS, Khuri FR, Shin DM, Myers JN, El-Naggar AK, Roach JS, Ginsberg LE, Thall PF, Wang X, Teddy S, Lawhorn KN, Zentgraf RE, Steinhaus GD, Pluda JM, Abbruzzese JL, Hong WK, Herbst RS. Tseng JE, et al. Among authors: herbst rs. Cancer. 2001 Nov 1;92(9):2364-73. doi: 10.1002/1097-0142(20011101)92:9<2364::aid-cncr1584>3.0.co;2-p. Cancer. 2001. PMID: 11745292 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

431 results

Search Page

Filters